A 8130

  • New York Assembly Bill
  • 2023 Regular Session
  • Introduced in Assembly
  • Assembly
  • Senate
  • Governor

Relates to the classification of the drug xylazine as a controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine

Abstract

Relates to the classification of the drug xylazine as a schedule I controlled substance, and to the criminal sale and possession of xylazine or preparations, compounds, mixtures or substances containing xylazine.

Bill Sponsors (22)

Votes


No votes to display

Actions


May 14, 2024

Assembly

HELD FOR CONSIDERATION IN HEALTH

Jan 03, 2024

Assembly

REFERRED TO HEALTH

Oct 13, 2023

Assembly

REFERRED TO HEALTH

Bill Text

Bill Text Versions Format
A8130 PDF HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the New York Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.